Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Mar 17, 2014 brown michael s Director Automatic Sell 2,000 333.42 - 336.49
Mar 17, 2014 brown michael s Director Option Execute 2,000 33.42
Mar 17, 2014 sanofi Beneficial Owner (10% or more) Buy 60,128 328.32 - 328.86
Mar 14, 2014 sanofi Beneficial Owner (10% or more) Buy 55,583 326.77 - 329.00
Mar 12, 2014 sanofi Beneficial Owner (10% or more) Buy 220,995 325.40 - 339.27
Mar 11, 2014 sanofi Beneficial Owner (10% or more) Buy 180,710 328.82 - 335.68
Mar 10, 2014 sanofi Beneficial Owner (10% or more) Buy 199,822 325.34 - 332.26
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 241,818 327.77 - 339.06
Mar 6, 2014 brown michael s Director Acquisition (Non Open Market) 2,700 n/a
Mar 6, 2014 sanofi Beneficial Owner (10% or more) Buy 80,404 338.64 - 339.82
Mar 3, 2014 sanofi Beneficial Owner (10% or more) Buy 251,594 328.00 - 339.94
Feb 27, 2014 brown michael s Director Sell 1,000 335.00
Feb 27, 2014 vagelos p roy Officer Option Execute 70,879 9.49 - 21.92
Feb 26, 2014 brown michael s Director Option Execute 1,000 57.11
Feb 25, 2014 goldberg murray a Officer Automatic Sell 11,871 336.89 - 346.73
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Feb 24, 2014 goldberg murray a Officer Automatic Sell 18,356 342.63
Feb 24, 2014 goldberg murray a Officer Option Execute 30,227 52.03 - 90.07
Feb 21, 2014 gilman alfred g Director Automatic Sell 5,000 340.00
Showing 101-120 of 867 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)